Antibodies, Anticardiolipin
"Antibodies, Anticardiolipin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN.
| Descriptor ID |
D017153
|
| MeSH Number(s) |
D12.776.124.486.485.114.323.210.100 D12.776.124.790.651.114.323.210.100 D12.776.377.715.548.114.323.210.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Anticardiolipin".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Anticardiolipin".
This graph shows the total number of publications written about "Antibodies, Anticardiolipin" by people in this website by year, and whether "Antibodies, Anticardiolipin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 2 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 5 | 7 |
| 2021 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Anticardiolipin" by people in Profiles.
-
The Role of Antiphospholipid Antibodies in COVID-19. Curr Rheumatol Rep. 2021 07 14; 23(9):72.
-
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders? Curr Rheumatol Rep. 2021 07 03; 23(8):65.
-
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Semin Thromb Hemost. 2022 Feb; 48(1):72-92.
-
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients. Ann Rheum Dis. 2021 09; 80(9):1236-1240.
-
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent. Autoimmun Rev. 2021 Jun; 20(6):102822.
-
Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies. Clin Rheumatol. 2021 Jul; 40(7):2939-2945.
-
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy. Arthritis Rheumatol. 2021 01; 73(1):173-174.
-
A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis. Pathobiology. 2021; 88(1):28-36.
-
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome. Front Immunol. 2020; 11:584241.
-
Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity. Arthritis Rheumatol. 2020 11; 72(11):1953-1955.